Highly pathogenic avian influenza virus (HPAI, such as H5N1) infection causes severe cytokine storm and fatal respiratory immunopathogenesis in human and animal. Although TGF-β1 and the integrin CD103 in CD8 + T cells play protective roles in H5N1 virus infection, it is not fully understood which key signaling proteins control the TGF-β1-integrin crosstalk in CD8 + T cells to protect from H5N1 virus infection. This study showed that ADAP (Adhesion and Degranulation-promoting Adapter Protein) formed a complex with TRAF6 and TAK1 in CD8 + T cells, and activated SMAD3 to increase autocrine TGF-β1 production. Further, TGF-β1 induced CD103 expression via an ADAP-, TRAF6-and SMAD3-dependent manner. In response to influenza virus infection (i.e. H5N1 or H1N1), lung infiltrating ADAP
CD8
+ T cells significantly reduced the expression levels of TGF-β1, CD103 and VLA-1.
ADAP -/-mice as well as Rag1 -/-mice receiving ADAP -/-T cells enhanced mortality with significant higher levels of inflammatory cytokines and chemokines in lungs. Together, we have demonstrated that ADAP regulates the positive feedback loop of TGF-β1 production and TGF-β1-induced CD103 expression in CD8 + T cells via the TβRI-TRAF6-TAK1-SMAD3 pathway and protects from influenza virus infection. It is critical to further explore whether the SNP polymorphisms located in human ADAP gene are associated with disease susceptibility in response to influenza virus infection.
Author Summary
Infection of avian influenza virus, especially the highly pathogenic strain H5N1, is a serious threat to public health worldwide, which causes severe fatal respiratory disease and
Introduction
H5N1 influenza viruses are highly pathogenic avian influenza (HPAI) virus, which also infect humans and cause fatal human respiratory diseases [1, 2] . Numerous animal or clinical studies have indicated that virus-induced cytokine dysregulation is one central reason for H5N1 pathogenesis and disease severity [2] [3] [4] . Compared with the influenza virus subtype H1N1, H5N1-infected patients showed unusually high serum levels of chemokines and inflammatory cytokines. And, H5N1-infected patients who died had higher serum levels of these mediators than those who survived [1, 2] . Mouse studies also suggest that sustained induction of the inflammatory response after H5N1 virus infection is correlated with the ability of H5N1 virus to disseminate to extrapulmonary organs [5] . Although the appearance of cytokine storm (also termed hypercytokinemia) is one of the most important features of H5N1 and H1N1 immunopathogenesis, mouse models deficient of cytokines IL-6 or MIP-1α show comparable mortality as influenza-challenged wild type controls [4, 6] . This might be due to the redundancy between cytokines or chemokines. Therefore, identification of other strategies to prevent cytokine storm or damage of respiratory tract is crucial and should shed new light on effective clinical anti-H5N1 or H1N1 treatment. Transforming growth factor β1 (TGF-β1) is the predominant member of the TGF-β isoforms in the immune system, and controls initiation and resolution of inflammation during multiple pathogenic progress, including influenza virus infection [7, 8] . TGF-β is secreted as an inactive precursor, which cannot bind to its receptor in its latent form (i.e. LTGF-β) [9] . The neuraminidase glycoprotein (NA) of most influenza strains including H1N1 could activate latent TGF-β (LTGF-β), while H5N1 cannot activate latent TGF-β [10, 11] . In agreement with the protective role of TGF-β during influenza virus infection, exogenous TGF-β delays mortality in H5N1-infected mice, and depletion of TGF-β increases mortality of H1N1 infection [10] . We aimed to dissect new mechanism of TGF-β production in host cells to ameliorate H5N1 or H1N1 virus infection.
Integrins have been identified to play critical roles in the regulation of TGF-β1 activation. Furthermore, once activated TGF-β1 binds to its heterodimeric receptor complex TβRI/II to induce SMAD-dependent or independent pathways, expression of multiple integrins is enhanced, including CD103 (also termed αEβ7) and VLA-1 (very late antigen-1, also termed α1β1) [12] . CD103 is preferentially expressed on CD8 + T cells specific for influenza but not for EBV or CMV, and maintains CD8 + T cells in lungs by binding to its ligand epithelial cadherin (E-Cadherin), which enhances immune surveillance to clear influenza infection [13, 14] . Despite of this, it remains to be elucidated which cytoplasmic effector(s) plays an indispensable role in the control of reciprocal TGF-β1-integrin crosstalk. We and others have demonstrated that upon infection or chemokine stimulation, T cells use the immune adaptor protein ADAP (adhesion and degranulation-promoting adapter protein, also known as Fyn-binding protein [Fyb] or SLP-76 associated protein of 130 kD ) to increase β2 integrin activation and adhesion [15] [16] [17] . However, it remains unclear whether ADAP regulates the expression of TGF-β1, CD103 and VLA-1 or controls the reciprocal TGF-β1-integrin crosstalk during influenza infection. In this study, we provided the first evidence that ADAP was indispensable for autocrine TGF-β1 production and CD103 expression via the TβR-TRAF6-ADAP-TAK1-SMAD3 pathway. Importantly, ADAP knock-out (KO) mice as well as Rag1 KO mice receiving ADAP KO T cells enhanced mortality in response to H5N1 or H1N1 infection, which displayed severe cytokine storm and lung damages with reduced levels of TGF-β1, CD103 and VLA-1 in CD8 + T cells.
Results

ADAP regulates TGF-β1 production in T cells via an autocrine manner
ADAP is an intracellular hematopoietic-specific adaptor protein that is constitutively and mainly expressed in T lymphocytes. Multiple studies have demonstrated that ADAP plays a crucial role in enhancing β2 integrin activation in response to antigen or chemokine stimulation [15, 16, 18, 19] . Since TGF-β1 and integrins have close relationship and function on each other, we asked whether ADAP regulated the crosstalk between integrins and TGF-β1. We first examined whether ADAP regulated TGF-β1 production in CD8 + cytotoxic T lymphocytes CTLs significantly reduced TGF-β1 production at precursor levels by anti-LAP (TGF-β1) staining (7.64% vs. 24.61%) or at mRNA levels by RT-PCR analysis (Fig 1A and 1B) . Next, ADAP was overexpressed in human C8166 T cell line, followed by stimulation with anti-CD3/ CD28 antibodies. ADAP overexpression enhanced LAP (TGF-β1) surface expression compared to the GFP controls ( Fig 1C, 74% vs. 43.7%). In agreement with this observation, wild type splenocytes enhanced LAP (TGF-β1) production after anti-CD3/CD28 stimulation, while ADAP -/-splenocytes failed to increase LAP (TGF-β1) production (1.29% vs. 13.8%, Fig 1D) .
Next, we measured the mature/active form and the inactive form of TGF-β1 by ELISA assay in wild type and ADAP -/-CD8 + CTLs after stimulation with OVA 257-264 peptide and exogenous TGF-β1. According to the manufactory's instruction, the mouse ELISA kit recognizes the mature/active form of TGF-β1. After samples received acid treatment and neutralization to remove LAP from TGF-β1 precursor, both active and inactive TGF-β1 in the supernatants could be detected by ELISA assay. We found that in response to OVA 257-264 peptide and exogenous TGF-β1 stimulation, ADAP deficient CD8 + CTLs indeed decreased both active and inactive TGF-β1 concentrations (Fig 1E) . It has been demonstrated that TGF-β1 production is regulated by an auto-feedback loop via TGF-β receptor I/II (TβRI/II) [20, 21] . TGF-β1 binds to a type II receptor, which recruits and phosphorylates the type I receptor TβRI. We observed that treatment with exogenous TGF-β1 enhanced the mRNA levels of TGF-β1 in OVA 257-264 -stimulated wild-type CD8 + OT1 Tg cells, (TGF-β1 ) and the relative mRNA levels of TGF-β1 in CD8 + CTLs from wild type or ADAP -/-OT1 Tg mice, which were generated with 10nM OVA 257-264 -peptide stimulation for 3 days. Data are representative of three independent experiments. (C) Human C8166 T cells overexpressing GFP or ADAP were stimulated with 2ug/mL plate bound anti-CD3/CD28 antibodies, followed by surface staining of LAP (TGF-β1). Data are representative of two independent experiments. (D) Wild type or ADAP -/-splenocytes were stimulated with 2ug/mL plate bound anti-CD3/CD28 antibodies, followed by surface staining of CD8 and LAP (TGF-β1). Data are representative of three independent experiments. (E) After stimulation with 5ng/mL TGF-β1 and 10nM OVA 257-264 -peptide for 6hrs, Wild type or ADAP -/-splenocytes were washed extensively and then incubated for further 18hr. Supernatants were collected to detect total TGF-β with ELISA. (F) In the presence or absence of the inhibitors SD208 and SB431542 (10uM respectively), the mRNA levels of TGF-β1 were examined in wild type or ADAP -/-splenocytes after stimulated with 10nM OVA 257-264 -peptide with or without 5ng/mL exogenous TGF-β1. Data are representative of three independent experiments. doi:10.1371/journal.ppat.1004824.g001
while ADAP -/-CD8 + OT1 Tg cells did not show this enhancement ( Fig 1E) . Next, the TGF-β receptor I kinase inhibitor SD208 or SB431542 was used to inhibit TGF-β signaling. In the presence of SD208 or SB431542, exogenous TGF-β1 failed to effectively induce TGF-β1 production in wild type cells, which was reduced to similar levels as that in ADAP -/-OT1 Tg cells (Fig 1F) . Together, we suggest ADAP as a critical intracellular effector for autocrine TGF-β1 production in T cells, which is dependent on TβRI kinase activity.
ADAP enhances TGF-β1/TβRI signaling via TRAF6-TAK1-SMAD3
Upon TGF-β1 stimulation, TβRI recruits and phosphorylates R-SMADs (receptor-regulated Smads, i.e. SMAD2 or SMAD3). R-SMADs then bind the common SMAD4 and enter the nucleus as transcription factors to induce expression of various genes, including TGF-β1 itself.
Given that ADAP was involved in TGF-β1/TβRI signaling for the induction of TGF-β1 (Fig 1) , we asked whether ADAP regulated the TβRI/II-induced SMAD activity. Jurkat T cells were transfected with GFP control or ADAP-GFP together with the (CAGA) 12 -luciferase or (SBE) 4 luciferase reporters respectively, which contain SMAD binding sequences [22, 23] . Exogenous TGF-β1 treatment increased the luciferase activity compared to untreated samples; and compared to the GFP control, ADAP overexpression further enhanced this by about 30% (Fig 2A,  left CTLs, while ADAP deficiency decreased SMAD3 nuclear translocation compared to wild type cells ( Fig 2C) .
As an immune adaptor protein, ADAP does not have kinase or enzyme activity, but contains several domains (i.e. proline-rich domain, SH3 domain and multiple tyrosines) for recruitment of other signaling proteins. To explore how ADAP was involved in TGF-β1 signaling, we overexpressed ADAP with SMAD2 or SMAD3 in 293T cells respectively, but did not find direct interaction between ADAP and SMAD2 or SMAD3 (S1A Fig). We next examined whether ADAP regulated the non-canonical SMAD signaling that participate in TGF-β1 production. Previous studies have shown interesting feature of the PI3K/AKT pathway, the MAPKs (mitogen-activated protein kinases) including p38 and JNK (c-Jun N-terminal kinase) to modulate SMAD activity [24] [25] [26] [27] [28] . In response to TGF-β1 and OVA peptide stimulation, our representative data showed that wild type and ADAP -/-CD8 + OT1 Tg cells displayed similar levels of p-p38, p-JNK, the PI3K subunit p-p85 (Tyr458) and p-AKT (Ser473) ( Fig 2D , the relative ratio compared to β-actin was shown in S1B Fig) . TAK1 (TGF-β activated kinase 1) is another non-canonical SMAD signaling protein to regulate SMAD3 activation [29] . The TβRI-TRAF6 interaction was previously identified for TGF-β-induced autoubiquitylation of TRAF6 and subsequent activation of TAK1 [30] . Interestingly, when GFP-tagged ADAP was co-transfected with Flag-tagged TRAF6 or HA-tagged TAK1 respectively in 293T cells, we observed direct binding of ADAP to TRAF6 (S1C Fig, left panel) . 12 -luciferase and (SBE) 4 -luciferase reporters respectively. After exogenous TGF-β1 treatment (5ng/mL), the luciferase activity was assessed. Data are representative of two independent experiments. (B) Wild type or ADAP -/-CD8 + OT1 CTLs were generated with 10nM OVA 257-264 peptide stimulation, then treated with 5ng/mL exogenous TGF-β1 as the indicated time points. The levels of pSMAD3 (ser 423/425), total SMAD3 and β-actin were examined. The relative ratio between p-SMAD3 and β-actin was shown. Data are representative of two independent experiments. (C) WT and ADAP KO CD8 + CTLs were treated with 5ng/mL TGF-β1 for 30min, followed by preparation of cytoplasmic and nuclear extracts. Equal amounts of cytoplasmic and nuclear extracts were loaded for western blotting assay with antibodies against SMAD3. SP1 expression in nuclear extracts and tubulin expression in cytoplasmic extracts were used as controls. Data are representative of two independent experiments. (D) Wild type or ADAP -/-CD8 + OT1 Tg cells were stimulated with 10nM OVA 257-264 peptide and 5ng/mL exogenous TGF-β1 as the indicated time points. The levels of p-p38, p-JNK, p-p85 (Tyr458), p-AKT (Ser473) and β-actin were examined. Data are representative of two independent experiments. (E) Cell lysates from OT-I CD8 + CTLs were immunoprecipitated
Although no direct interaction between ADAP and TAK1, co-transfection of TRAF6 could bring ADAP and TAK1 into the same complex (S1C Fig, right panel) . We next examined whether endogenous ADAP interacted with TRAF6 in primary CD8 + CTLs. Anti-TRAF6 immunorecipitation was performed followed by immunoblotting with antibodies against ADAP and TAK1. We confirmed that endogenous TRAF6 indeed forms a complex with ADAP and TAK1 in primary CD8 + T cells (Fig 2E) .
To test whether TAK1 played a central role together with ADAP in TGF-β1 production, wild type and ADAP -/-CD8 + OT1 CTLs were stimulated with OVA peptide and exogenous TGF-β1 in the presence of the TAK1 inhibitor 5Z-7-oxozeaenol. The mRNA levels of TGF-β1 were profoundly decreased by 5Z-7-oxozeaenol treatment, and no difference was detected between wile type and ADAP -/-CD8 + OT1 CTLs ( Fig 2F) . Together, these data suggest that ADAP forms a signaling module with TRAF6 and TAK1 to enhance TGF-β1-induced SMAD3 activation and TGF-β1 production via an autocrine manner.
ADAP -/-mice enhanced mortality with reduced TGF-1 production in response to H5N1 virus infection
Since TGF-β has been identified to play a protective role during the influenza H5N1 virus infection [10] , we asked whether and how ADAP regulated H5N1 virus infection. Previously reports showed that ADAP deficient mice have normal T cell development in thymus and normal percentages or numbers of mature peripheral T cells [15] [16] [17] . Wild type and ADAP -/-mice were challenged with the H5N1 strain A/DK/GuangXi/12/03 that was isolated from ducks in China (i.e. termed GX/12 in this paper) [31] . As reported earlier [31] , the infected wild type mice started to recover from day 8 and remained survival. In contrast, the infected ADAP -/-mice markedly lost bodyweight and 100% died around day 10 post infection ( Fig 3A) .
In the PBS-treated mock control groups, ADAP -/-mice and wild type mice showed normal lung structure without immune cell infiltration. At day 10 post infection, lungs from ADAP -/-mice were swollen with increased weight compared to those from wild type mice (Fig 3B) . Substantially, lung structure was disrupted with massive infiltration of immune cells in the H5N1-infected ADAP -/-mice by H&E staining (Fig 3C) . At day 10 post infection, the number of infiltrated CD8 + T cells into BAL (bronchoalveolar lavage) of lungs was significantly enhanced in the infected ADAP -/-mice examined by FACS analysis or by IHC staining (Fig 3D) . 
Severe inflammation and lung damage of H5N1-infected ADAP -/-mice
In agreement with the impaired TGF-β1 production in CD8 + T cells and ADAP -/-lungs, we detected cytokine storm phenotype in H5N1-infected ADAP deficient mice. The relative mRNA levels of IL-1β, IL-6, TNFα and IFNγ were markedly increased in lungs from H5N1-infected ADAP -/-mice with no significant changes of IL-4 ( Fig 4A) . Besides TGF-β1, IL-10 could also inhibit cytokine production. However, we found no significant difference of IL-10 mRNA levels in lungs between H5N1-infected wild type and ADAP -/-mice ( Fig 4A, right panel) . Importantly, we also observed much higher levels of chemokines in lungs of H5N1-infected ADAP -/-mice, including CCL2/MCP-1 (Monocyte Chemotactic Protein-1), CCL3/MIP-1α (Macrophage Inflammatory Protein-1α), CCL5 and CXCL10/IP-10 (Interferon-γ-inducible Protein) (Fig 4B) . This might attract more immune cells to migrate from spleen to lung (S3D Fig) and enhance the number of lung infiltrating ADAP -/-CD8 + T cells (Fig 3D) .
Uncontrolled lung inflammation was account for the destructive structure of respiratory tract in H5N1-infected ADAP -/-mice, including alveoli, bronchioles and bronchus of lungs (Fig 4C) . This suggests that ADAP deficiency induces a possible link between reduced TGF-β1 production and declined lung function with acute lung inflammation.
ADAP deficiency reduces TGF-1-induced CD103 expression in CD8 + T cells TGF-β1 signaling has been reported to induce and maintain integrin CD103 expression preferentially on influenza-specific CD8 + T cells, and CD103 + CD8 + T cells plays a protective role in the control of influenza infection [13] . We therefore examined CD103 expression on ADAP deficient CD8 + T cells after H5N1 infection. Compared to that of the H5N1-infected wild type mice, surface CD103 expression on ADAP -/-CD8 + T cells from BAL and MLNs was decreased (Fig 5A and 5B, percentages and MFI/Mean Fluorescence Intensity of CD103 + staining). The reduced CD103 mRNA levels were also observed in lungs of the infected ADAP -/-mice ( Fig 5C, left panel) . The expression of the CD103 ligand E-cadherin was not significantly affected by ADAP deficiency, which is mainly expressed in lung endothelial cells (Fig 5C, right panel) . Next, we used exogenous TGF-β1 and anti-CD3/CD28 treatment to induce CD103 expression in wild type or ADAP deficient CD8 + CTLs in vitro. The mRNA levels of CD103 were profoundly reduced in ADAP -/-CD8 + CTLs compared to those in wild type cells (Fig 5D) . After treated with different concentrations of exogenous TGF-β1, surface CD103 expression was (Fig 5G) . Together, we propose that TβRI, TAK1, TRAF6 and ADAP are indispensable for TGF-β1-induced CD103 expression.
ADAP deficiency decreases VLA-1 expression in CD8 + T cells with increased amount of H5N1 virus
As another critical integrin, VLA-1 (very late antigen-1, also termed α1β1) was reported to regulate CD8 + T cell-mediated immune protection against influenza infection [14] . In addition, β1 integrin has been suggested for LAP-TGF-β1 activation [35] . Interestingly, at day 10 post H5N1 virus infection, ADAP -/-CD8 + CTLs in BAL reduced VLA-1 expression on cell surface 
Rag1 -/-mice receiving ADAP -/-T cells reduces protection and CD103 expression in response to H5N1 virus infection
To confirm that ADAP deficiency in T cells represented the main reason to cause more severe H5N1 virus infection, we transferred wild type or ADAP -/-T cells into Rag1 -/-recipient mice.
The comparable percentages of CD8 + T cells were detected in MLN and spleens in these Four days after adaptive T-cell transfer, these mice were infected with the H5N1 virus strain GX/12. Rag1 -/-mice received ADAP -/-T cells significantly reduced body weight, compared to those receiving wild type T cells (Fig 7A) . HE staining showed that more immune cells were infiltrated into lungs of the Rag1 -/-recipient mice that were adoptively transferred with ADAP T cells (Fig 7B) . Furthermore, the lung infiltrating ADAP -/-CD8 + T cells significantly reduced surface CD103 expression (Fig 7C) . These findings have demonstrated that ADAP deficiency impairs T cell-mediated protection against H5N1 virus infection.
ADAP -/-mice enhance mortality with defective expression of TGF-1 and CD103 in response to H1N1 infection
To assess whether ADAP regulates infection of other influenza virus subtype (i.e. not HPAI), wild type and ADAP -/-mice were intranasally infected with the H1N1 virus strain A/PR8.
Compared to wild type mice, ADAP -/-mice showed heightened mortality within shorter periods after A/PR8 infection (Fig 8A) . We observed that the A/PR8-infected ADAP -/-mice had edematous lungs with enhanced weight and numbers of lung infiltrating immune cells (Fig 8B  and 8C ). At day 8 post infection, the mRNA level of viral PR8 in the lungs of ADAP deficient mice was significantly higher than that of wild type mice (Fig 8D) . Moreover, the number of CD8 + T cells in BAL of lungs was significantly enhanced in the A/PR8-infected ADAP -/-mice examined by FACS or real-time PCR (Fig 8E) . Similar to the results of H5N1 infection, concentrations of active and total TGF-β1 in lungs were severely decreased in H1N1-infected ADAP -/-mice compared to those from wild type mice (Fig 8F) . Previous studies have demonstrated that highly elevated IL-6, IL-1, TNF-α, IFN-γ, MIP, CXCL10 are major causes of ARDS (acute respiratory distress syndrome) and mortality [4, 6, 36, 37] , and TGF-β1 could restrict inflammatory response. In agreement with the reduced TGF-β1 production, we detected markedly increased mRNA levels of IL-6, TNFα and IFNγ (Fig 8G) or CCL2, CCL3, CCL5 and CXCL10 (Fig 8H) in lungs from A/PR8-infected ADAP -/-mice. By contrast, IL-4 or IL10 expression was not substantially changed (Fig 8G) . Similar to H5N1 infection, we also detected reduced surface CD103 levels in lung infiltrating ADAP deficient CD8 + T cells (Fig 8I) . Taken together, ADAP enhances TGF-β1 production and signaling, and is indispensable for protection against H1N1 and H5N1 virus infection. 
Discussion
As the highly pathogenic avian influenza (HPAI), H5N1 virus infection induces unbalanced host immune responses with highly elevated cytokines and significant lung pathology [36] [37] [38] . TGF-β1 is suggested to suppress cytokine storm during H5N1 virus infection [10] . Since HPAI loads and replicates in the respiratory tract for much longer time than seasonal influenza [2] , viral antigen activated T cells become one of the major sources to produce TGF-β1. In this study, we observed the enhanced mortality in the H5N1-or H1N1-infected ADAP KO mice and this could be possibly explained by three main findings including (1) defective TGF-β production and TGF-β signaling; (2) cytokine storm; (3) reduced CD103 expression. Previous studies suggest the protective role of TGF-β to control initiation and resolution of inflammation, while CD103 + CD8 + T cell-mediated immune responses play vital roles in recovery from H5N1 virus infection [39] . Our study has provided the first evidence that CD8 + T cells secreted TGF-β1 in an autocrine manner via the TβRI-TRAF6/ADAP/TAK1-SMAD3 pathway (Fig 1) . Further, ADAP forms a complex with TRAF6/TAK1 in CD8 + T cells to regulate SMAD3 activation and TGF-β-induced CD103 expression (Figs 2 and 4) . Consistent with the in vitro findings, H5N1-infected ADAP KO mice reduce TGF-β production and CD103 expression (Figs 3 and 5). Moreover, the reduced TGF-β production was correlated to the elevated levels of inflammatory cytokines and chemokines in H5N1-or H1N1-infected ADAP KO mice (Figs 3 and 8). We further used Rag1 KO mice that were adoptively transferred with ADAP KO T cells to demonstrate that ADAP deficient T cells play a direct role in protection against virus infection (Fig 7) . These observations together suggest the enhanced mortality in ADAP KO mice was closely related to the defective TGF-β production and signaling. To demonstrate a direct link of the ADAP KO mortality phenotype to TGF-β, it is better to set a 'rescue' experiment provided by TGF-β1 or TGF-β1 receptor, which protects ADAP KO mice effectively as the wild type control mice. Since ADAP deficient T cells not only decreased TGF-β1 production, but also poorly responded to TGF-β1 signaling, we were unable to expect a miraculous reversal of lung pathology or reduction of mortality in ADAP -/-mice after exogenous injection of TGF-β1. Together, this study suggests that ADAP is indispensable for TGF-β1 production and TGF-β1-triggered CD103 expression via the TβRI-, TRAF6-, TAK1-dependent manner and protects from influenza virus infection.
Although mature TGF-β1 plays a critical role in the suppression of cytokine storm, H5N1 virus fails to activate the latent form of TGF-β1 (LAP-TGF-β1) [10] . We have observed that ADAP controls surface expression levels of VLA-1 (i.e. α1β1) in lung infiltrating CD8 + T cells during H5N1 virus infection (Fig 6) . β1 integrin has been suggested for LAP-TGF-β1 activation [35] , and TGF-β1 regulates expression of various β1 integrins. It is likely that ADAP is indispensable for CD8 + T cells to (1) promote VLA-1 expression, which activates LAP-TGF-β1 on neighboring immune cells to release active TGF-β1; (2) produce autocrine or paracrine TGF-β1, which then binds TβRI on CD8 + T cells to amplify the reciprocal TGF-β1-integrin crosstalk.
Interestingly, the combination of TGF-β1 and TCR stimulation could induce CD103 expression as well as FoxP3 expression, which are both dependent on SMAD2/3 and NFAT1 [40] . In agreement with this line, alloantigen-induced CD103 + CD8 + T cells display strong suppressive activity in a mixed lymphocyte culture [41] . In addition, our recent findings suggest that ADAP deficient CD8 + T cells enhance cytotoxicity to kill tumor cells. Since ADAP deficient CD8 + T cells reduce TGF-β1/CD103 expression and decrease the ability to protect from H5N1 virus infection, further investigation should ask whether ADAP regulates suppressive function of CD103 + CD8 + T cells, whether the TGF-β1/TβRI-ADAP-TRAF6-TAK1 pathway represents a general mechanism for reciprocal TGF-β1-integrin crosstalk to mediate inflammation-associated autoimmune diseases or graft transplantation. Past efforts have identified various SNPs (Single Nucleotide Polymorphisms) or mutations in key molecules of TGF-β1 pathway, which are associated with inflammatory, infections or human cancer including TGFB1, TβRI/II, SMADs, Foxo3A [42] [43] [44] . Interestingly, a recent study has found an association between polymorphisms located in ADAP/FYB gene and Systemic Lupus Erythematosus (SLE) [45] . Considering high mortality of humans in H5N1 virus infection, it is critical to investigate whether these human SNPs or mutations in TGF-β1-regulated pathway (including the ADAP gene) could possibly enhance disease susceptibility or clinical manifestations in response to acute H5N1 virus infection. 
Methods
Mice and ethics statement
Viral infection
The H5N1 virus A/Duck/Guangxi/12/2003 (termed GX/12) was used which was isolated from ducks in China. The viruses were propagated in 10-day-old specific-pathogen-free embryonated eggs and were stored at -70°C. Mice were lightly anesthetized with CO 2 and were challenged intranasally with 10 6 50% egg infectious doses (EID 50 ) of GX/12 in a volume of 50 μl. A/PR8 virus, kindly provided by Prof. Dongming Zhou (Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China), was grown in embryonated chicken eggs, and titrated for mean lethal dose (LD50) in adult C57BL/6 mice. C57BL/6 mice were inoculated intranasally with 10 LD50 of A/PR8 virus. At the indicated time points, samples from the infected mice were collected for RNA extraction or preparation of tissue lymphocytes. The remaining mice were monitored for 14 days for weight loss and mortality. Animal experiments were performed at least two independent times. 
T cell adoptive transfer
Preparation of tissue lymphocytes
Briefly, BAL fluids from the infected mice were collected by lavage with 1ml PBS for three to five times. Or, MLN and spleen were homogenized, filtered through 70 μm nylon mesh; and red blood cell were lysed and removed. Immune cells were collected after extensive wash with PBS.
ELISA assay
Lung was harvested and homogenized in 1mL 1×PBS on ice. Serum was gained in blood after clots were formed at 4°C. TGF-β1 concentrations in lung homogenate, serum, and supernatant from cell cultures were quantified by ELISA according to the manufacture's instruction (Westong Biotechnology, Shanghai). The TGF-β ELISA kit recognizes the mature/active form of TGF-β1 and does not detect the latent form of TGF-β1. To measure the total concentration of TGF-β1 (both active and latent form), samples required acid-treatment and neutralization to remove LAP from the latent TGF-β1. Active TGF-β1 in samples was assayed without acid treatment.
Histology and immunohistochemistry
Lungs from the H5N1 virus infected mice were collected at the indicated time points, fixed in formalin and embedded in paraffin. Sections were cut and stained with hematoxylin and eosin (H&E) or immunohistochemistry (IHC). The relative degree of lung inflammation and tissue damage were examined and scored using the method described previously [46, 47] . Briefly, lung infiltration of inflammatory cells was scored as follows: 0, no inflammation; 1, mild peribronchial and peribronchiolar infiltrates, extending throughout, 10% of the lung; 2, moderate inflammation covering 10-50% of the lung; 3, severe inflammation involving over one-half of the lung. Degeneration of bronchi and bronchiolar epithelium, alveoli degeneration and collapse was scored as follows: 0, no degeneration; 1, little vacuolar degeneration of bronchi and bronchial epithelium cells, normal pulmonary alveoli; 2, mild necrosis of bronchi and bronchial epithelium, mild alveoli damage; 3, severe degeneration. Necrosis was scored as follows: 0, no necrosis; 1, mild necrosis with scant exudate; 2, marked necrosis with abundant exudate; 3, severe interstitial edema around blood vessels, apparent injured parenchyma and alveolar epithelial cells with greater infiltration of inflammatory cells.
TGF-β1 induction in vitro
To check whether ADAP regulated TGF-β1 production in vitro, naïve splenocytes from WT or ADAP -/-OT1 Tg mice were stimulated with 10nM OVA 257-264 and 20U/ml human recombinant IL-2 for 3 days to generate CD8 + CTLs. Alternatively, splenocytes from WT or ADAP -/-mice or C8166 T cell lines overexpressing GFP or ADAP-GFP were stimulated with 2ug/mL plate bound anti-CD3/CD28 antibody for 3 days. Cells were harvested to examine surface expression by anti-LAP (TGF-β1) staining or TGF-β1 mRNA levels by RT-PCR. To block TGF-β signaling, splenocytes from WT or ADAP -/-OT1 Tg mice were stimulated with 10nM OVA 257-264 and 5ng/mL exogenous TGF-β1 in presence or absence of the TGF-β receptor I kinase inhibitor SD208 or SB431542 (10uM). TGF-β1 mRNA levels were then measured by RT-PCR.
Flow cytometry
Lymphocytes from each organ was stained with various combinations of mAbs to CD4-FITC/ APC, CD8α-PE/APC, CD3α-PE, and B220-FITC (eBiosciences), CD103-APC, LAP (TGF-β1)-PE (Clone TW7-20B9, Biolegend 
Luciferase reporter assay
Wild type Jurkat, ADAP deficient Jurkat (JDAP cells) or ADAP overexpressing Jurkat cells were transfected with (CAGA) 12 -luciferase or (SBE) 4 -luciferase reporter plasmids respectively. Cells were then stimulated with 5ng/mL exogenous TGF-β1 for 6-8 hrs, followed by measurement of luciferase activity using Dual-Glo luciferase system (Gibco).
Western blot assay CD8 + CTL cells generated with 10nM OVA 257-264 treatment from WT and ADAP -/-OT1 Tg mice were left unstimulated or stimulated with 5ug/mL TGF-β1 for different time points. Cell lysates were prepared for immunoblotting with the indicated antibodies. To quantify the amount of nuclear SMAD3, WT and ADAP KO CD8 + CTLs were treated with 5ng/mL TGF-β1 for 30min. The extraction of cytoplasmic and nuclear protein was performed according to the product manufacturer instructions. Equal amounts of cytoplasmic and nuclear extract were loaded for western blotting assay with antibodies against SMAD3, SP1 and tubulin.
RNA extraction and real-time PCR analysis
Total RNA was extracted from tissues or cells using Trizol reagent (Invitrogen) following the supplier's protocol and first-strand cDNA was synthesized using M-MLV Reverse Transcriptase RNase H Minus (Promega). Relative quantitative Real-Time PCR was carried out on BIO-RAD CFX96 Touch TM Real-Time PCR Detection System (BIO RAD) using Bestar TM Real-Time PCR Master Mix (SYBR Green methods, DBI Bioscience) with 2 -44 CT method.
Actin was used as the reference gene. All primer sequences are listed in Table 1 .
CD103 induction in vitro
Naïve splenocytes from WT and ADAP -/-OT1 Tg mice were stimulated with 10nM OVA [257] [258] [259] [260] [261] [262] [263] [264] in presence of different concentrations of TGF-β1 for 3 days, CD103 + CD8 + CTLs were identified by staining with anti-mouse CD8-FITC and anti-mouse CD103-APC. Alternatively, to examine surface CD103 expression, CD8 + T cells were purified with BD IMag™ CD8+ Magnetic Particles;
WT and ADAP -/-CD8 + T cells were stimulated with 2ug/mL plate bound anti-CD3/CD28 and 5ng/mL exogenous TGF-β1 in the presence of the TAK1 inhibitor 5Z-7-oxo (2uM) or the TGF-β receptor I kinase inhibitor SB431542 (10uM); WT and TRAF6 +/-CD8 + T cells were stimulated with 2ug/mL plate bound anti-CD3/CD28 and different concentrations of exogenous TGF-β1 for 3 days.
Statistical analysis
Data were analyzed using unpaired two tailed Student's t test. Survival rates were analyzed by log-rank (Mantel-Cox) test. p value <0.05 or <0.01 was marked as Ã or ÃÃ respectively.
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